ReadyCell S.L. was proud to recently welcome our colleagues and partners from SOLVO Biotechnology to our facilities in the Barcelona Science Park. SOLVO Biotechnology is a leading provider of transporter services and products for pharmaceutical, biotechnological, and CRO companies. We had the pleasure to welcome their representatives Nóra Kormos, Nikoletta Geltsch and Zsolt Fekete to discuss different topics related to quality, commercial, and new collaboration scenarios.

ReadyCell team is pleased to announce that we have completed a successful large distance shipment from our production facilities in Spain to South Korea, a new market for us with a lot of potential. We are happy to slowly being recognized in Asian countries such as Japan and India, and now as well in South Korea.Wherever you are based is not inconvenient for getting our kits in your facilities. Thanks to our Shipping Medium, a

Receiving South Korean partner in BarcelonaThe Readycell team was glad to welcome Nexel’s CEO Dr. Choonseong Han, and Nexel’s Business Manager, Dr. Hayden Lee to visit our facilities in the city of Barcelona in July 2018. Nexel is a biotechnology company based in Seoul, S. Korea, an expert in producing iPSC derived cell-products for in-vitro toxicology screenings. ReadyCell and Nexel first met in Boston in the context of the BioUSA conference, and both companies’ complementarities

Developing new trans-Atlantic partnerships June of 2018 has been an important month for ReadyCell, due to our participation in this year’s BIO International Convention held in the city of Boston, Massachusetts, during the 4th – 7th of June. Our colleague Gerard Palau had the chance to meet with Spanish representatives in the Spanish Pavilion, and also, he has met with a remarkable number of scientists, Business Developers, and CEO’s of different Pharma, Biotech and CRO

R&D Projects: developing different products based on the same cellular origin The main objective for this project involves the completion of the set of HepatoReady products, iniciated in 2014 (Project financed by ACCIÓ, numer RD14 1-0087) and includes the following technical objectives: 1. Develop a method that allows isolated hepatocyte cryopreservation from human tissue, that constitutes a better option for their long term storage, and it offers a permanent supply of product. 2. Develop a

Expanding R&D staff and activities ReadyCell is pleased to announce its newest member Dr. María Vázquez-Sánchez, who joins ReadyCell team as a Head of R&D. Within her role, María will support the development of new in-vitro, ready-to-use tools, for ADME/DMPK studies. Welcome on board, María!

Crossing the Channel to show our added value ReadyCell committed to visit key customers and potential new clients in the British territory, in order to raise awareness of our existing products as well as to receive feedback from Key Opinion Leaders from the Bioscience sectors. ReadyCell’s representatives will travel to important UK cities such as Nottingham, Cambridge and London, and visit companies such as Sygnature Discovery, Pharmaron UK, and Astex Therapeutics as key companies in

Join us at the Annual ADME & Predictive Toxicology meeting in Barcelona Select Biosciences organized the 7th Annual ADME & Predictive Toxicology meeting in Barcelona, and ReadyCell participated with a poster presentation in the event. During the meeting (18-19th Feb, Barcelona) ReadyCell presented some preliminary results regarding Solid Shipping Medium new applications. Francisco Torres, Sales Manager and Scientific advisor attended to the meeting with a poster showing how Ready-to-Use technology could be eventually applied to

ReadyCell going to India to develop new business opportunities. ReadyCell joined two weeks ago a catalan commercial mission organized by ACCIÓ. During this business trip, ReadyCell representative Francisco Miguel Torres (Sales Manager and Scientific Advisor) visited many Indian top pharmaceutical companies, discussing their potential needs in the ADME-Tox segment and different partering oportunities. ReadyCell also participated in three different B2B events (Delhi, Mumbai and Bangalore), broading its contact network within the indian market and establishing

Meet ReadyCell at CPhI Worlwide! ReadyCell will attend to the CHpI Worldwide convention in Frankfurt (22-24 October 2013). This is the world’s leading pharmaceutical networking event, and is co-located with many other interesting events such ICSE, P-MEC and InnoPack. CHpI will host over 30,000 attendees from 140 countries and 2,200 exhibitors, and is a key meeting point for pharmaceutical companies. Find out more information in the official website: CHpI Worldwide